Literature DB >> 33291728

Meningococcal Vaccines: Challenges and Prospects.

Priyal Bagwe1, Lotika Bajaj1, Rikhav Gala2, Susu M Zughaier3, Mohammad N Uddin1, Martin J D'Souza1.   

Abstract

Neisseria meningitidis is a gram-negative bacterium that causes a severe acute infection, called the meningococcal disease [...].

Entities:  

Year:  2020        PMID： 33291728      PMCID： PMC7761900          DOI： 10.3390/vaccines8040738

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN： 2076-393X


  7 in total

1.  Heterogeneity in non-epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis.

Authors:  Kathryn A Matthias; Michael Brad Strader; Hesham F Nawar; Yamei S Gao; Joonseong Lee; Dhilon S Patel; Wonpil Im; Margaret C Bash
Journal:  Mol Microbiol       Date:  2017-08-01       Impact factor: 3.501

2.  Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.

Authors:  Magdalena K Bielecka; Nathalie Devos; Mélanie Gilbert; Miao-Chiu Hung; Vincent Weynants; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

3.  Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine.

Authors:  Rikhav P Gala; Martin D'Souza; Susu M Zughaier
Journal:  Vaccine       Date:  2016-05-10       Impact factor: 3.641

Review 4.  The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.

Authors:  Ray Borrow; Pedro Alarcón; Josefina Carlos; Dominique A Caugant; Hannah Christensen; Roberto Debbag; Philippe De Wals; Gabriela Echániz-Aviles; Jamie Findlow; Chris Head; Daphne Holt; Hajime Kamiya; Samir K Saha; Sergey Sidorenko; Muhamed-Kheir Taha; Caroline Trotter; Julio A Vázquez Moreno; Anne von Gottberg; Marco A P Sáfadi
Journal:  Expert Rev Vaccines       Date:  2016-11-22       Impact factor: 5.217

Review 5.  Meningococcal Vaccines: Current Status and Emerging Strategies.

Authors:  Pumtiwitt C McCarthy; Abeer Sharyan; Laleh Sheikhi Moghaddam
Journal:  Vaccines (Basel)       Date:  2018-02-25

Review 6.  Recent Progress in the Prevention of Serogroup B Meningococcal Disease.

Authors:  Ian M Feavers; Martin C J Maiden
Journal:  Clin Vaccine Immunol       Date:  2017-05-05

Review 7.  Meningococcal serogroup B vaccines: Estimating breadth of coverage.

Authors:  Robert G K Donald; Julio Cesar Hawkins; Li Hao; Paul Liberator; Thomas R Jones; Shannon L Harris; John L Perez; Joseph J Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452
  7 in total
  1 in total

1.  Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation.

Authors:  Priyal Bagwe; Lotika Bajaj; Rikhav P Gala; Martin J D'Souza; Susu M Zughaier
Journal:  Vaccines (Basel)       Date:  2022-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.